AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,303,000 | +7.0% | 1,992,022 | +22.4% | 0.06% | +17.0% |
| Q2 2023 | $46,076,000 | +38.6% | 1,626,960 | +12.4% | 0.05% | +35.9% |
| Q1 2023 | $33,247,000 | -16.2% | 1,447,388 | +2.5% | 0.04% | -17.0% |
| Q4 2022 | $39,660,000 | +1.9% | 1,412,409 | +2.6% | 0.05% | -2.1% |
| Q3 2022 | $38,934,000 | +29.9% | 1,376,239 | +1.8% | 0.05% | +41.2% |
| Q2 2022 | $29,976,000 | -29.7% | 1,352,111 | -7.7% | 0.03% | +6.2% |
| Q1 2022 | $42,644,000 | +11.5% | 1,464,932 | +25.9% | 0.03% | 0.0% |
| Q4 2021 | $38,260,000 | -28.2% | 1,163,984 | +0.7% | 0.03% | -28.9% |
| Q3 2021 | $53,320,000 | -16.2% | 1,155,360 | +0.1% | 0.04% | -13.5% |
| Q2 2021 | $63,637,000 | +8.5% | 1,154,724 | +1.6% | 0.05% | -37.3% |
| Q1 2021 | $58,676,000 | +23.6% | 1,136,257 | +3.7% | 0.08% | +20.3% |
| Q4 2020 | $47,487,000 | +9.9% | 1,095,947 | -11.2% | 0.07% | -5.5% |
| Q3 2020 | $43,194,000 | -34.3% | 1,234,135 | +0.4% | 0.07% | -35.4% |
| Q2 2020 | $65,746,000 | +64.0% | 1,229,350 | +8.8% | 0.11% | +37.8% |
| Q1 2020 | $40,092,000 | -19.6% | 1,130,017 | +8.2% | 0.08% | +15.5% |
| Q4 2019 | $49,857,000 | +82.3% | 1,044,127 | +23.7% | 0.07% | +54.3% |
| Q3 2019 | $27,347,000 | +11062.0% | 844,030 | +22866.8% | 0.05% | – |
| Q3 2017 | $245,000 | -63.8% | 3,675 | -77.9% | 0.00% | -100.0% |
| Q1 2016 | $676,000 | -67.7% | 16,644 | -48.3% | 0.00% | -75.0% |
| Q4 2015 | $2,092,000 | +6.2% | 32,218 | +15.5% | 0.00% | 0.0% |
| Q3 2015 | $1,969,000 | -34.8% | 27,887 | +2.5% | 0.00% | -33.3% |
| Q2 2015 | $3,022,000 | +45.0% | 27,195 | +23.1% | 0.01% | +50.0% |
| Q1 2015 | $2,084,000 | +44.8% | 22,095 | +72.0% | 0.00% | +33.3% |
| Q4 2014 | $1,439,000 | +1430.9% | 12,844 | +432.7% | 0.00% | – |
| Q1 2014 | $94,000 | – | 2,411 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |